Anti-P-Selectin / CD62p Reference Antibody (crizanlizumab)
- Product Code: 140432
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20℃ |
Product Description:
Used primarily in the management of sickle cell disease, this antibody targets P-selectin to reduce the frequency of vaso-occlusive crises. By inhibiting cell adhesion, it helps maintain blood flow and prevents blockage in small vessels. It is administered intravenously and has shown efficacy in reducing pain episodes in patients, especially those unresponsive to other treatments. Its application extends to improving quality of life and reducing hospitalizations related to acute complications of sickle cell disease.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 50μg | 10-20 days | ฿4,980.00 |
+
-
|
Anti-P-Selectin / CD62p Reference Antibody (crizanlizumab)
Used primarily in the management of sickle cell disease, this antibody targets P-selectin to reduce the frequency of vaso-occlusive crises. By inhibiting cell adhesion, it helps maintain blood flow and prevents blockage in small vessels. It is administered intravenously and has shown efficacy in reducing pain episodes in patients, especially those unresponsive to other treatments. Its application extends to improving quality of life and reducing hospitalizations related to acute complications of sickle cell disease.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :